首页> 外文会议>7th Asian-Pacific Conference on Medical and Biological Engineering(第七届亚太地区生物工程学术会议)论文集 >Coating preparation and drug delayed release of dexamethasone-eluting intravascular stents in vitro and in vivo
【24h】

Coating preparation and drug delayed release of dexamethasone-eluting intravascular stents in vitro and in vivo

机译:地塞米松洗脱血管内支架的体内外制备及药物延迟释放

获取原文

摘要

To prepare the dexamethasone-eluting intravascular stents by dip coating and then to observe the character of drug delayed release in vitro and in vivo in the stents.Methods Stents were prepared by dip coating.High performance liquid chromatography (HPLC) was used to detect the drug loading of the stents.The weight of bare stents and drug eluting stents was determined in order to know the weight percentage of drugs in the coating.Thermal analyzer was used to analyse the melting point of dexamethasone.The drug slow-release rate in vitro was detected with the flow chamber.The buffer solution was taken out at the scheduled time.The dexamethasoneeluting intravascular stents were implanted into the rabbit abdominal aorta.The tissues of the vessel wall and liver were employed for the detection of the drug slow-release properties in vivo.The data collected were analyzed by using SPSS 12.0.Results The drug loading level increased in a time-dependent manner and peaked 93.15 μg at 4 d.The level of the loaded drug in the coating was (13.70±0.84)%.Differential scanning calorimetry (DSC) indicated that the melting point was 259.3°C,accordant with the related literatures.Drugs were released slowly and the release rate reached 84% at 15 d.The drug concentration was detected after stent implantation.Conclusion Drugs remained 16% of the total loaded drug at 15 d and the drug concentration in the vessel wall and liver tissues was detected after stent implantation,suggesting that the prepared stents may be helpful for the slow-release of dexamethasone.
机译:通过浸涂制备地塞米松洗脱的血管内支架,然后观察体外药物延迟释放的特征和在支架中的体内。通过浸涂制备了支架。使用液相色谱(HPLC)来检测药物装载的药物装载。确定裸架和药物洗脱支架的重量,以了解涂层中药物的重量百分比。热分析仪用于分析地塞米松的熔点。药物缓释率在体外用流动室检测。在预定时间中取出缓冲溶液。将地甲基甲基脲酸舒服的血管内支架植入兔腹主动脉中。使用血管壁和肝脏的组织用于检测药物缓释性能在体内。通过使用SPSS 12.0来分析收集的数据。方法以时间依赖的方式增加药物负载水平,并在4 d处达到93.15μg。水平涂层中的装载药物是(13.70±0.84)%。差示扫描量热法(DSC)表明熔点为259.3°C,与相关文献含量释放。缓慢释放,释放速率在15℃下达到84% D.在支架植入后检测到药物浓度。结论药物在15d下留下总负载药物的16%,并且在支架植入后检测到血管壁和肝组织中的药物浓度,表明准备好的支架可能有所帮助地塞米松的缓慢释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号